CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Acolye Numbing Cream Anorectal(Hemorrhoidal) Cream

5% Lidocaine· ingredient lidocaineAmides· LIDOCAINE .05 g/g; LIDOCAINE 1.5 g/30g; LIDOCAINE 3 g/60g; LIDOCAINE 4 g/80g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.35967
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other lidocaine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Burn Relief$0.02792−$0.33170
ALCEMISTE$0.05101−$0.30870
Lidocaine Viscous$0.07984−$0.27980
Lidocaine$0.09024−$0.26940
lidocaine$0.15755−$0.20210
Cadira Compliant Blood Stat$0.21848−$0.14120
LIDOCAINE HCl$0.24343−$0.11620
Lidocaine$0.35160−$0.00810

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.